Morgan Stanley issues callable notes due 2031
Morgan Stanley Finance LLC priced a series of fixed-rate callable notes due May 15, 2031, fully and unconditionally guaranteed by Morgan Stanley.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Morgan Stanley Finance LLC priced a series of fixed-rate callable notes due May 15, 2031, fully and unconditionally guaranteed by Morgan Stanley. Each note has a stated principal of $1,000, a coupon of 4.550% per annum, semi-annual interest and an initial interest payment on November 15, 2026. The notes are callable on specified dates in 2027 based on the output of a risk neutral valuation model; any redemption will pay 100% of principal plus accrued interest. The issuer estimates the note value on the pricing date at approximately $981.60 per note. All payments remain subject to Morgan Stanley's credit risk.
Insights
Callable structure with model-based call gives issuer optionality; investors face reinvestment and credit risk.
The notes pay a 4.550% fixed coupon to May 15, 2031 with semi-annual payments and an initial payment on November 15, 2026. The early redemption is governed by a risk neutral valuation model that compares issuance economics and references issuer credit spreads set at pricing.
Key dependencies include Morgan Stanley's credit spreads and the model inputs selected by the calculation agent. Because redemption is model-driven, investors should note potential early call on the listed 2027 redemption dates and limited secondary liquidity.
Estimated pricing shows issuance costs embedded; estimated value below par reflects dealer costs and hedging.
The issuer reports an estimated value of $981.60 per note on the pricing date, within $51.60 of that estimate. This gap reflects issuance, structuring and hedging costs borne by investors and dealer commissions described in the supplement.
Secondary market prices may be lower than issue price; the notes are unlisted and MS & Co. may or may not make a market. Cash‑flow treatment is standard: principal and interest subject to Morgan Stanley credit risk.
Key Figures
Key Terms
risk neutral valuation model financial
call feature financial
30/360 (Bond Basis) financial
book-entry technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the headline terms of the MS callable notes?
How and when can Morgan Stanley (MS) call these notes?
What is the estimated value at pricing for the MS notes?
Are payments on these MS notes guaranteed or insured?
Will there be an active secondary market for these MS notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.